Valent BioSciences LLC has acquired FBSciences Holdings, Inc. With this acquisition, Valent BioSciences and its parent company, Sumitomo Chemical Co., Ltd., now offer integrated biorational solutions, including biostimulants, biopesticides and crop nutrition solutions.
The acquisition of FBSciences, a leader in biostimulants headquartered in Collierville, Tennessee, strengthens Valent BioSciences’ participation in the growing $3.5 billion global biostimulant market. On October 1, 2022, Valent BioSciences began selling biostimulant products directly to its U.S. customer base.
FBSciences’ portfolio of biorational technologies is naturally derived, renewable and sustainable, and forms the foundation of a wide offering of innovative solutions for agriculture. The company’s core technologies are derived from natural organic matter utilizing proprietary production processes that target and extract a diverse mixture of unique and biologically active compounds that transform plant, soil and climate health. The company’s flagship biostimulant technology, FBS Transit, forms the foundation of its crop nutrition and nutrient use efficiency product lines for use on all crops. Its biopesticide technology, FBS Defense, works within the plant to increase its ability to defend itself from biotic stresses, including insects and diseases.
“The acquisition of FBSciences is a natural next step in the evolution of our organization as a global leader in biorationals, including biostimulants,” said Ted Melnik, president and CEO of Valent BioSciences. “Our combined organizations have many decades of experience leading our respective markets with science-based technology and innovation. The wide range of biostimulant, biopesticide, and crop nutrition products and technologies in the FBSciences portfolio augments Valent BioSciences’ broad family of biorational products, thereby creating an unmatched range of value-added and sustainable solutions that no other company can provide.”
According to Courtenay Wolfe, CEO and chairwoman of FBSciences, the acquisition of FBSciences by Valent BioSciences is a “major leap forward for the biorational industry. Our companies share a common rooted-in-science approach coupled with a mission to better society and our planet. Adding FBSciences’ expertise, innovative solutions and entrepreneurial spirit to Valent BioSciences’ global powerhouse of resources and robust solutions will deliver a platform unrivaled in the industry and continue to propel Valent BioSciences’ leadership position in the rapidly growing biorational space.”
Read the NOV/DEC 2022 issue of New AG International’s leading quarterly title, here.
Read the SEP/OCT 2022 issue of New AG International’s leading quarterly title, here.